>>> US Gapping up

Gapping up
In reaction to earnings/guidance:

  • GBT +15.2%, INSP +14.3%, CERS +11.3%, COUR +10.7%, NVTA +10.5%, NPTN +9.9%, HZNP +9.3%, BXC +9.1%, SPNS +8.2%, TUP +7.4%, GDOT +7%, PAYC +6.4%, DVA +5.5%, VECO +5.3%, JLL +5.3%, ATVI +5.2%, UTHR +5.2%, GEO +4.5%, CLH +4.1%, NEWR +3.9%, MTOR +3.7%, SBGI +3.7%, OI +3.5%, PUMP +3.5%, LYV +3.4%, TX +3.3%, WK +3.3%, RNG +3.2%, RGA +3.1%, DENN +3.1%, BNFT +2.9%, SRC +2.8%, CZR +2.5%, SKY +2.4%, SPR +2.3%, IOSP +2.1%, FNF +2% (also raises dividend and announces 25 mln share repurchase authorization), XP +2%, SKT +1.9%, LL +1.9%, AFG +1.7%, NMIH +1.6%, CRTO +1.6%, MCHP +1.4% (also raises dividend), SPT +1.4%, EDIT +1.4%, CIM +1.3%, FRG +1.2%, RDN +1.2%, SMG +1.2%, ABC +1.1%, EXC +1.1%, FDP +1%, LYFT +0.9%, CAR +0.9%, MAC +0.9%, APAM +0.8%, PSA +0.8%, QUAD +0.8%, CDW +0.8%

Other news:

  • BYSI +193.4% (reports top-line results from DUBLIN-3 trial)
  • LMRK +20.4% (receives $16.25/unit asset purchase proposal from Melody Investment Advisors)
  • OBSV +5.2% (announces two cornerstone publications describing clinical trials of Nolasiban for improving pregnancy and live birth outcomes following IVF)
  • MGM +3.9% (entered into agreement with VICI Properties (VICI) and MGM Growth Properties (MGP) to redeem majority of MGP units held by MGM for $43/unit; MGP to be acquire by VICI in stock-for-stock deal)
  • INVE +3.7% (CFO steps down)
  • AMSC +3% (announces $21 mln of new energy power system orders)
  • NRXP +3% (signed an agreement with MannKind Corporation (MNKD) to develop a dry powder formulation of ZYESAMI)
  • MCFE +2.6% (declares special cash dividend of $4.50/sh)
  • RIGL +1.6% (files for $100 mln mixed securities shelf offering)
  • NOG +1.6% (increases dividend)
  • CWH +1.5% (increases stock buyback program by $125 mln)
  • AFRM +1.2% (follow up to report that co will partne with Apple for buy now, pay later service)
  • PFE +1.2% (top-line results from the Phase 2b/3 ALLEGRO trial)

Analyst comments:

  • BHG +3.8% (upgraded to Buy from Neutral at Citigroup)
  • BJRI +2.8% (upgraded to Buy from Hold at Deutsche Bank)
  • UAA +2.8% (upgraded to Overweight from Neutral at JP Morgan)
  • SHEN +2.2% (upgraded to Mkt Perform from Underperform at Raymond James)